InvestorsHub Logo
Followers 36
Posts 2689
Boards Moderated 0
Alias Born 06/09/2011

Re: Cannonblack5 post# 84948

Wednesday, 11/23/2016 10:32:47 AM

Wednesday, November 23, 2016 10:32:47 AM

Post# of 696849
Cannonblack5, I had not seen this interview before but you are dead on with her long term strategy from this interview. I also noted the following on Fraunhofer expansion from this interview. Thanks for sharing this link.

http://www.blackandwhiteprogram.com/interview/northwest-biotherapeutics-inc-nwbo-ob-interview-with-linda-f-powers-ceo

It’s really significant in some of the ways that are similar to why the Fraunhofer Partnership in Germany (we already announced) is so significant. Number one, it’s a large-scale organization. It’s a very highly respected organization by all parties, by physicians, by patients and importantly by regulators. They have large-scale capacity. They have existing physical facilities, GMP Clean Room facilities to make the cellular product in, and they had experience for ten years in working with other versions of immune therapies. Just like Fraunhofer, they have actually dedicated their existing GMP facility to our programs. It’s a small one but they’re in the process of constructing a much larger one as well so it brings us all of those things. And partnering with them gives us access to the UK market, a major market. One of the leaders in the European Unions, especially for these kinds of medical products. The UK has been very much at the forefront of novel medicines and, from a regulatory standpoint, encouraging novel medicines

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News